Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket

CNBC • U.S. • 27 minutes ago

Lilly hiked its full-year sales outlook by $2 billion, and also raised its adjusted profit guidance.

Read from Source (Read More) ← Back to Homepage # U.S.

Transgender Idaho Residents Sue After State Criminalizes Use of Bathrooms

The lawsuit seeks to block a state bathroom law that is the nation’s most restrictive, with penalties that could includ…

Merck narrowed its 2026 sales guidance and hiked its adjusted profit outlook.

Eli Lilly is slated to report first-quarter earnings before the bell on Thursday, in one of the most closely watched re…

The defense secretary said at a House hearing that President Barack Obama had fired 197 generals, a figure that the Pen…

During his first public appearance on Capitol Hill since the war began, the defense secretary lashed out at lawmakers i…

Sen. Jeff Merkley, D-Ore., led a letter — first reported by CNBC — to the CFTC asking for stricter rules for companies …